Clinical Trial Update: BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions [NA]

View source ↗

Summary

BIOFLOW-INDIA trial evaluating the safety and clinical performance of Biotronik's Orsiro sirolimus-eluting stent in single de novo coronary artery lesions has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Orsiro Drug-Eluting Stent (sirolimus-eluting stent)

Snippet

Sponsor: Biotronik AG | Conditions: Coronary Artery Disease | NA | Status: COMPLETED